Tropoxane

From Self-sufficiency
Revision as of 00:09, 14 March 2010 by حسن علي البط (Talk) (Removed category Stimulants; Quick-adding category Organochlorides (using HotCat))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Tropoxane
220px
Systematic (IUPAC) name
methyl (1R,2S,3S,5S)-3-(3,4-dichlorophenyl)-8-oxabicyclo[3.2.1]octane-2-carboxylate
Identifiers
ATC code none
PubChem CID 9796921
Chemical data
Formula C15H16Cl2O3
Molar mass 315.192[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Tropoxane is an aryloxytropane derivative drug developed by Organix Inc,[1] which acts as a stimulant and potent dopamine and serotonin reuptake inhibitor. It is an analogue of dichloropane where the amine nitrogen has been replaced by an oxygen ether link (at the bridgehead position), demonstrating that the amine nitrogen is not required for DAT binding and reuptake inhibition.[2][3][4]

P. Meltzer et al. made some 8-thiabicyclo(3.2.1)octanes recently (2007).

For SAR purposes, a table has been included that lists some of these compounds.

MAT IC50 (nM) 8-thiabicyclo[3.2.1]octanes
X Com DAT SERT Com DAT SERT Com DAT SERT
H1a910>10uM2a140>8uM3a117>3uM
F1b220>30uM2b59>11uM3b38494
Cl1c13>10uM2c111uM3c9.633
Br1d9.1>25uM2d6.03423d6.014
I1e6.7>8uM2e9.0703e1410
Cl21f4.5>3uM2f6.9993f5.78.0
BN1g8.0>1uM2g8.0363g1613

It had been hypothesized that transporter binding of the tropanes might include ionic bonding of the central tropane nitrogen. But it turned out that at this site neither ionic nor hydrogen bonding is a prerequisite for potent monoamine reuptake inhibition. Oxa- and thia-analogs of RTI-111 are potent inhibitors, and even an N-replacement by methylene holds the potency within the same magnitude.[5] However, N-quaternisation ('N-dimethyl') considerably reduces DAT affinity.

2

In this SAR, the focus is on seeing the effect of changing 8-NMe to S, O, or CH2.

Both enantiomers, as well as the racemates are presented in several cases for comparison.

MAT IC50 (nM) Cl2 bicyclo[3.2.1]octanes
Enant. X Com DAT SERT Com DAT SERT Com DAT SERT
RacS1a4.53,600 2a6.9993a5.78.0
RacO1a106,0002a3.164.53a3.36.5
1RNMe1a1.28672a0.4273a1.12.5
RacCH21a7.15,1602a131663a9.633

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

  1. Bertha K Madras and Peter C Meltzer. Bridge-substituted Tropanes and Uses. WIPO Patent WO/1997/040859
  2. Madras BK, Pristupa ZB, Niznik HB, Liang AY, Blundell P, Gonzalez MD, Meltzer PC. Nitrogen-based drugs are not essential for blockade of monoamine transporters. Synapse. 1996 Dec;24(4):340-8. PMID 10638825
  3. Meltzer PC, Liang AY, Blundell P, Gonzalez MD, Chen Z, George C, Madras BK. 2-Carbomethoxy-3-aryl-8-oxabicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters. Journal of Medicinal Chemistry. 1997 Aug 15;40(17):2661-73. PMID 9276012
  4. Madras BK, Miller GM, Meltzer PC, Brownell AL, Fischman AJ. Molecular and regional targets of cocaine in primate brain: liberation from prosaic views. Addiction Biology 2006;5(3):351-359.
  5. a) [1] Synthesis of 8-thiabicyclo[3.2.1]octanes and Their Binding Affinity for the Dopamine and Serotonin Transporters. Pham-Huu D-P, Deschamps JR, Liu S, Madras BK, Meltzer PC, Bioorg Med Chem. 2007, 15(2): 1067–82. PMID 17070057
    b) PMID 14612136 Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. Madras BK et al. Eur J Pharmacol. 2003; 479(1-3): 41-51. c) Compare PMID 11746710 Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates? Goulet M, Miller GM, Bendor J, Liu S, Meltzer PC, Madras BK. Synapse 2001, 42(3): 129-40.